23:15:21 EDT Fri 12 Aug 2022
Enter Symbol
or Name

Login ID:
Symbol GBLT
Shares Issued 113,328,091
Close 2022-05-16 C$ 0.06
Recent Sedar Documents

ORIGINAL: GBLT Receives $1.1M CAD Order for Their Household Healthcare Products from a Major International Retailer

2022-05-17 10:27 ET - News Release

GBLT Receives $1.1M CAD Order for Their Household Healthcare Products from a Major International Retailer

Canada NewsWire

TORONTO and DUEREN, Germany, May 17, 2022 /CNW/ - GBLT Corp. (TSXV: GBLT) ("GBLT" or the "Company") is pleased to announce that it has secured an order for their household healthcare consumer electronics with one of the largest international retailers in the world valued at euros814,000 ($1,100,000 CAD)*.

"We continue to focus on growing our high margin Dr. Senst household healthcare products and is pleased to continue our ongoing relationship with this major global retailer who has been our customer since we have started our Dr. Senst household healthcare line," said Dr. Thilo Senst, CEO of GBLT. "We are experiencing a growing demand for household healthcare products, and we are continuing to capitalize on this trend. We have well-established relationships with some of the largest retailers globally and continue to build on this strong foundation to provide a stable and growing cashflow for the foreseeable future."

*Source https://www.bankofcanada.ca/rates/exchange/daily-exchange-rates/ (1.3537 CAD/EU Rate as of 2022-05-03)

About GBLT:

GBLT Corp., through its operating company, GBT GmbH, designs, manufactures and supplies mobile storage, and battery solutions. GBLT is also a leading provider of renewable energy solutions via its solar division, participating in the rapidly growing solar energy market. In addition, the Company offers consumer healthcare and wellness products to some of the largest retail chains across the globe. GBT is also an official licensee for AGFAPHOTO mobile energy products. The Company's branded healthcare and wellbeing products are primarily sold throughout Europe under Dr. Senst brand.

For more information, please visit www.gbt-international.com and www.gbltcorp.com.

Forward-Looking Information

Certain statements in this news release, which are not historical in nature, constitute "forward looking statements" within the meaning of that phrase under applicable Canadian securities law. These statements include, but are not limited to, statements or information concerning the Company's proposed activities under the Agreement, the Company's ability to achieve sales, commercial or otherwise, from its products, and the expectations of the Company regarding funding payments due pursuant to the Agreement. These statements reflect management's current assumptions and expectations and by their nature are subject to certain underlying assumptions, known and unknown risks and uncertainties and other factors which may cause actual results, performance or events to be materially different from those expressed or implied by such forward looking statements. Except as required pursuant to applicable securities laws, the Company will not update these forward-looking statements to reflect events or circumstances after the date hereof. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by the Company. Readers are cautioned not to place undue reliance on forward looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


View original content: http://www.newswire.ca/en/releases/archive/May2022/17/c9610.html


GBLT Corp., Dr. Thilo Senst, CEO, Tel.: +49(0)2421-20856-0, Email: investor@gbltcorp.com; Investor Relations: Virtus Advisory Group, Tel: 416-644-5081, Email: info@virtusadvisory.com

© 2022 Canjex Publishing Ltd. All rights reserved.